Schedule 13G ownership disclosure

SILO PHARMA INC COM

Security class unavailable · CUSIP: 82711P201

Event date: 2023-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
0
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-24-006557
Form type
SC 13G/A
Filer
Reda Joseph
CIK
CIK 1952100
Filed
Jan 25, 2024
Reporting period
Dec 31, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub